Natco Pharma

Quarterly
Consolidated
ParticularsSep '25Dec '25Mar '26Jun '26Sep '26
Revenue1,463705.40816.90794.401,019
Expenses849.30544.30672.80608.80776.20
EBITDA679.20216.80205.40245.70310.00
EBIT626.80170.60155.00198.60260.80
Profit Before Tax613.70161.10144.10185.60243.20
Net Profit517.90140.40233.30122.20173.40
Financial Ratios
Operating Profit Margin49.83%33.49%27.79%33.42%32.05%
Net Profit Margin38.03%23.40%36.25%28.09%20.94%
Earning Per Share (Diluted)28.948.4614.9611.5311.31
Dividends Per Share1.501.500.000.000.00